Stock dilution

HUMBL Cancels Reverse Stock Split

Retrieved on: 
Wednesday, February 22, 2023

San Diego, California, Feb. 22, 2023 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTCQB: HMBL) announced today that the Company has decided to cancel its application for a 1:10 reverse split of its common stock with FINRA.

Key Points: 
  • San Diego, California, Feb. 22, 2023 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTCQB: HMBL) announced today that the Company has decided to cancel its application for a 1:10 reverse split of its common stock with FINRA.
  • On February 10th, HUMBL launched the first mobile wallet with digital assets, a search engine and verified social media profiles in one application.
  • Further, HUMBL is in the process of aggressively settling legacy debt and recapitalizing the Company with the goal of less dilutive financing,” said Brian Foote, CEO of HUMBL.
  • “We also revisited the purpose of the reverse split and believe it is neither aligned with our current objectives, nor particularly beneficial for our retail shareholders at this juncture.”

Riskified Exceeds Annual Guidance for 2022; Diversified Model Well-Positioned for Continued Success in 2023

Retrieved on: 
Thursday, February 23, 2023

As we look forward to 2023, we remain excited about the opportunities ahead.

Key Points: 
  • As we look forward to 2023, we remain excited about the opportunities ahead.
  • (1) GMV is a key performance indicator and Adjusted EBITDA is a non-GAAP measure of financial performance.
  • The Company will host a conference call to discuss its financial results today, February 23, 2023 at 8:30 a.m. Eastern Time.
  • A live webcast of the call can be accessed from Riskified’s Investor Relations website at ir.riskified.com.

Allegion Reports Fourth-Quarter, Full-Year 2022 Financial Results, Introduces 2023 Outlook

Retrieved on: 
Wednesday, February 22, 2023

“The Allegion team delivered another quarter of excellent operational performance,” said John H. Stone, Allegion president and CEO.

Key Points: 
  • “The Allegion team delivered another quarter of excellent operational performance,” said John H. Stone, Allegion president and CEO.
  • Fourth-quarter 2022 operating income was $159.4 million, an increase of $44.3 million or 38.5 percent compared to 2021.
  • Adjusted operating income in fourth-quarter 2022 was $167.6 million, an increase of $51.3 million or 44.1 percent compared to 2021.
  • “Our focus on operational excellence and investing for growth – paired with healthy demand in electronics and non-residential markets – gives Allegion strong momentum as we enter 2023,” Stone said.

Aimco Provides Recent Highlights and Fourth Quarter Financial Results

Retrieved on: 
Tuesday, February 21, 2023

Apartment Investment and Management Company (“Aimco”) (NYSE: AIV) announced today fourth quarter and full year results for 2022 and provided highlights on recent activities and an outlook for 2023.

Key Points: 
  • Apartment Investment and Management Company (“Aimco”) (NYSE: AIV) announced today fourth quarter and full year results for 2022 and provided highlights on recent activities and an outlook for 2023.
  • In the fourth quarter, Aimco and its joint venture partner began construction on the 220-apartment home development at Strathmore Square in Bethesda, Maryland.
  • Aimco plans to start pre-leasing Upton’s 689 apartment homes during the summer of 2023 in anticipation of initial delivery in the fourth quarter of 2023.
  • Aimco expects to deliver the first homes in the third quarter with pre-leasing efforts having begun in the first quarter of 2023.

EQS-News: Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors

Retrieved on: 
Wednesday, February 22, 2023

Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax said: “We are excited to announce today’s successful pricing of Abivax’s oversubscribed capital increase of EUR 130M, with a balanced mix of top-tier existing and new investors, mostly US biotech specialists.

Key Points: 
  • Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax said: “We are excited to announce today’s successful pricing of Abivax’s oversubscribed capital increase of EUR 130M, with a balanced mix of top-tier existing and new investors, mostly US biotech specialists.
  • The Abivax team is fully focused on making obefazimod rapidly accessible to all the patients in need.”
    Didier Blondel, CFO of Abivax, added: “We are extremely pleased to announce our successful EUR 130M capital increase at market price.
  • Abivax, once again, could attract new top-tier US and European biotech investors, including Great Point Partners, LLC, Deerfield Management Company, Commodore Capital, Samsara BioCapital, Boxer Capital and a few additional great names, as well as most of our existing US and European biotech investors.
  • Investors participating in the Capital Increase have not taken any lock-up undertakings relating to the shares subscribed in the framework of the Capital Increase.

Reed’s, Inc. Announces Transition from the Nasdaq Capital Market to the OTCQX and Close of $2.5 Million Bridge Financing

Retrieved on: 
Tuesday, February 14, 2023

Reed’s was given until February 13, 2023 to regain compliance with Nasdaq’s bid price rule and the minimum stockholders’ equity rule for continued listing on the Nasdaq Capital Market.

Key Points: 
  • Reed’s was given until February 13, 2023 to regain compliance with Nasdaq’s bid price rule and the minimum stockholders’ equity rule for continued listing on the Nasdaq Capital Market.
  • Reed’s received notice from The Nasdaq Stock Market LLC (“Nasdaq”) on February 14, 2023, that the staff of Nasdaq’s Listing Qualifications department (the “Staff”) has determined that the Company’s securities will be delisted from Nasdaq.
  • Trading in the Company’s securities will be suspended from the Nasdaq Capital Market at the opening of business on February 16, 2023.
  • In addition to its transition to the OTCQX, Reed’s is announcing the close of a bridge financing with Whitebox Advisors, LLC for net proceeds of approximately $2.5 million.

Nickel 28 Responds to Value Destructive, Highly Dilutive, Unsolicited and Non-binding Financing Proposal From Shareholder, Announces New Independent Director

Retrieved on: 
Wednesday, February 8, 2023

Nickel 28 Capital Corp. (“Nickel 28” or the “Company”) (TSXV: NKL) (FSE: 3JC0) today publicly responds to an unsolicited, non-biding and self-serving proposal received from a shareholder of the Company.

Key Points: 
  • Nickel 28 Capital Corp. (“Nickel 28” or the “Company”) (TSXV: NKL) (FSE: 3JC0) today publicly responds to an unsolicited, non-biding and self-serving proposal received from a shareholder of the Company.
  • Nickel 28 is issuing this news release so that all shareholders are made aware of the Company’s response to these self-serving demands.
  • Following review, the Board has unanimously determined that the unsolicited proposal is not value enhancing for the Company or its shareholders, other than for the shareholder making the proposal.
  • Nickel 28 is pleased to announce today the appointment of Lance C. Frericks to the Board of Directors, effective immediately.

ELS Declares First Quarter 2023 Dividend

Retrieved on: 
Tuesday, February 7, 2023

On February 7, 2023, the Board of Directors of Equity LifeStyle Properties, Inc. (NYSE:ELS) (referred to herein as “we,” “us,” and “our”) declared a first quarter 2023 dividend of $0.4475 per common share, representing, on an annualized basis, a dividend of $1.79 per common share.

Key Points: 
  • On February 7, 2023, the Board of Directors of Equity LifeStyle Properties, Inc. (NYSE:ELS) (referred to herein as “we,” “us,” and “our”) declared a first quarter 2023 dividend of $0.4475 per common share, representing, on an annualized basis, a dividend of $1.79 per common share.
  • The dividend will be paid on April 14, 2023 to stockholders of record at the close of business on March 31, 2023.
  • This press release includes certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
  • As with any projection or forecast, these statements are inherently susceptible to uncertainty and changes in circumstances.

onsemi Exceeds Fourth Quarter Expectations and Announces $3 Billion Share Repurchase Program

Retrieved on: 
Monday, February 6, 2023

These special items are out of our control and could change significantly from period to period.

Key Points: 
  • These special items are out of our control and could change significantly from period to period.
  • The reconciliation that is unavailable would include a forward-looking income statement, balance sheet and statement of cash flows in accordance with GAAP.
  • We use these measures, together with GAAP measures, for internal managerial purposes and as a means to evaluate period-to-period comparisons.
  • However, we do not, and you should not, rely on non-GAAP financial measures alone as measures of our performance.

Faraday Future Announces $135 Million in Convertible Secured Notes Financing Commitments Which are Expected to Provide the Company with Sufficient Funding to Reach its FF 91 Futurist Start of Production Milestone in March 2023

Retrieved on: 
Monday, February 6, 2023

Once consummated on the contemplated timeline, the Company is expected to have raised all the necessary funds for the start of production (“SOP”) of the FF 91 Futurist.

Key Points: 
  • Once consummated on the contemplated timeline, the Company is expected to have raised all the necessary funds for the start of production (“SOP”) of the FF 91 Futurist.
  • This proposal, if approved by Faraday Future stockholders, will clear the path for additional future financing to best support FF 91 Futurist deliveries and the Company’s other strategic goals.
  • “Securing $135.0 million in funding commitments is critical and imperative for Faraday Future’s sprint to FF 91 Futurist's SOP.
  • The availability of these additional funding commitments provides confidence that FF can reach the SOP milestone in March 2023.